-
Autism CBD Trial On Children Advances As Israeli Company Enrolls First Five Patients
Tuesday, August 20, 2024 - 3:28pm | 501SciSparc Ltd. (NASDAQ:SPRC) announced on Tuesday that the first five patients have been enrolled and dosed into its ongoing clinical trial in children suffering from autism spectrum disorder (ASD) at the Soroka Medical Center in Israel. What Happened The Israeli specialty clinical-stage...
-
IGC Trials Research Effective THC Drug Dosing For Alzheimer's Patients
Thursday, December 9, 2021 - 12:26pm | 501India Globalization Capital, Inc. (AMEX: IGC) revealed the preliminary results of its exploratory endpoints from a Phase 1 clinical trial of a THC-drug to treat Alzheimer’s symptoms. The Phase 1 clinical trial provided valuable insights on Pharmacokinetics (PK) and genotyping...